These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21784624)

  • 1. Baseline severity but not gender modulates quantified Crataegus extract effects in early heart failure--a pooled analysis of clinical trials.
    Eggeling T; Regitz-Zagrosek V; Zimmermann A; Burkart M
    Phytomedicine; 2011 Nov; 18(14):1214-9. PubMed ID: 21784624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].
    Rietbrock N; Hamel M; Hempel B; Mitrovic V; Schmidt T; Wolf GK
    Arzneimittelforschung; 2001 Oct; 51(10):793-8. PubMed ID: 11715631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
    Habs M
    Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():36-9. PubMed ID: 15353901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
    Degenring FH; Suter A; Weber M; Saller R
    Phytomedicine; 2003; 10(5):363-9. PubMed ID: 12833999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II.
    Zapfe jun G
    Phytomedicine; 2001 Jul; 8(4):262-6. PubMed ID: 11515715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Crataegus special extract WS 1442 in the treatment of early stages of CHD-associated heart failure].
    Koller M; Lorenz W; Aubke W; Jensen A; Gerlach FM; Kuhl J; Pfeil T; Regitz-Zagrosek V; Rusche H; Rychlik R
    MMW Fortschr Med; 2006 Feb; 148(6):42. PubMed ID: 16526340
    [No Abstract]   [Full Text] [Related]  

  • 7. Hawthorn extract for treating chronic heart failure.
    Pittler MH; Guo R; Ernst E
    Cochrane Database Syst Rev; 2008 Jan; (1):CD005312. PubMed ID: 18254076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Crataegus Special Extract WS 1442 in NYHA II heart failure. A placebo controlled randomized double-blind study].
    Leuchtgens H
    Fortschr Med; 1993 Jul; 111(20-21):352-4. PubMed ID: 8375791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)].
    Weikl A; Assmus KD; Neukum-Schmidt A; Schmitz J; Zapfe G; Noh HS; Siegrist J
    Fortschr Med; 1996 Aug; 114(24):291-6. PubMed ID: 8974970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of Crataegus extract WS 1442 in patients with heart failure: the SPICE trial.
    Holubarsch CJ; Colucci WS; Meinertz T; Gaus W; Tendera M;
    Eur J Heart Fail; 2008 Dec; 10(12):1255-63. PubMed ID: 19019730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health effects of hawthorn.
    Dahmer S; Scott E
    Am Fam Physician; 2010 Feb; 81(4):465-8. PubMed ID: 20148500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials.
    Pittler MH; Schmidt K; Ernst E
    Am J Med; 2003 Jun; 114(8):665-74. PubMed ID: 12798455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of Crataegus oxycantha Special Extract WS 1442 on clinical progression in patients with mild to moderate symptoms of heart failure.
    Zick SM; Gillespie B; Aaronson KD
    Eur J Heart Fail; 2008 Jun; 10(6):587-93. PubMed ID: 18490196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) trial.
    Zick SM; Vautaw BM; Gillespie B; Aaronson KD
    Eur J Heart Fail; 2009 Oct; 11(10):990-9. PubMed ID: 19789403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of crataegus extract WS 1442 in comparison with placebo in patients with chronic stable New York Heart Association class-III heart failure.
    Tauchert M
    Am Heart J; 2002 May; 143(5):910-5. PubMed ID: 12040357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatigue as a predictor of outcome in patients with heart failure: analysis of CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).
    Perez-Moreno AC; Jhund PS; Macdonald MR; Petrie MC; Cleland JG; Böhm M; van Veldhuisen DJ; Gullestad L; Wikstrand J; Kjekshus J; Lewsey JD; McMurray JJ
    JACC Heart Fail; 2014 Apr; 2(2):187-97. PubMed ID: 24720928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hawthorn extract improves chronic heart failure.
    Eaton LJ; Kinkade S
    J Fam Pract; 2003 Oct; 52(10):753-4. PubMed ID: 14529593
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.
    Kosmala W; Holland DJ; Rojek A; Wright L; Przewlocka-Kosmala M; Marwick TH
    J Am Coll Cardiol; 2013 Oct; 62(15):1330-8. PubMed ID: 23916925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac function after CPAP therapy in patients with chronic heart failure and sleep apnea: a multicenter study.
    Egea CJ; Aizpuru F; Pinto JA; Ayuela JM; Ballester E; Zamarrón C; Sojo A; Montserrat JM; Barbe F; Alonso-Gomez AM; Rubio R; Lobo JL; Duran-Cantolla J; Zorrilla V; Nuñez R; Cortés J; Jiménez A; Cifrián J; Ortega M; Carpizo R; Sánchez A; Terán J; Iglesias L; Fernández C; Alonso ML; Cordero J; Roig E; Pérez F; Muxi A; Gude F; Amaro A; Calvo U; Masa JF; Utrabo I; Porras Y; Lanchas I; Sánchez E;
    Sleep Med; 2008 Aug; 9(6):660-6. PubMed ID: 17904420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High-dose Crataegus extract WS 1442 in the treatment of NYHA stage II heart failure].
    Tauchert M; Gildor A; Lipinski J
    Herz; 1999 Oct; 24(6):465-74; discussion 475. PubMed ID: 10546150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.